Accumulating evidence has shown the importance of Stat6-mediated signaling in allergic diseases. In this study, we show a novel regulatory mechanism of Stat6-mediated signaling in mast cells. When Stat6 is activated by interleukin (IL)-4 and translocated to the nucleus, Stat6 is cleaved by a nucleus-associated protease in mast cells. The cleaved 65-kD Stat6 lacks the COOH-terminal transactivation domain and functions as a dominant-negative molecule to Stat6-mediated transcription. The retrovirus-mediated expression of cleavage-resistant Stat6 mutants prolongs the nuclear accumulation of Stat6 upon IL-4 stimulation and enhances IL-4–induced gene expression and growth inhibition in mast cells. These results indicate that the proteolytic processing of Stat6 functions as a lineage-specific negative regulator of Stat6-dependent signaling in mast cells, and thus suggest that it may account for the limited role of Stat6 in IL-4 signaling in mast cells.
Proteolytic Processing of Stat6 Signaling in Mast Cells as a Negative Regulatory Mechanism
K. Suzuki and H. Nakajima contributed equally to this work.
Abbreviations used in this paper: aa, amino acid; AEBSF, 4-(2-aminoethyl)-benzenesulfonyl fluoride hydrochloride; BMMC, bone marrow–derived mast cell; GFP, green fluorescent protein; IRES, internal ribosome entry site; JAK, Janus kinase; MMP, matrix metalloproteinase; MSCV, murine stem cell virus; PCMB, p-chloromercuribenzoate; WT, wild-type.
Kotaro Suzuki, Hiroshi Nakajima, Shin-ichiro Kagami, Akira Suto, Kei Ikeda, Koichi Hirose, Takaki Hiwasa, Kiyoshi Takeda, Yasushi Saito, Shizuo Akira, Itsuo Iwamoto; Proteolytic Processing of Stat6 Signaling in Mast Cells as a Negative Regulatory Mechanism . J Exp Med 1 July 2002; 196 (1): 27–38. doi: https://doi.org/10.1084/jem.20011682
Download citation file:
Sign in
Client Account
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement